So I was searching online and I found this article about a company named ReNetX Bio that has just announced the initiation of a Series A financing round to fund its first clinical trial of its lead therapeutic candidate, Nogo Trap, in patients with chronic spinal cord injury. I personally think it's awesome that more people are doing or are planning do clinical trails for Chronic SCI.


Company Website:

Yale Discovery: